The Center for Advanced Forensic DNA Analysis Appoints Leading Science and Technology Advisor

Share Article

Genome ID Group, LLC, d/b/a, The Center for Advanced Forensic DNA Analysis TM (CAFDA) is pleased to announce the appointment of Sandra L. Close (Kirkwood) PhD. as Chief Science and Technology Advisor. This important appointment adds significant expertise in the application of whole genome array technology and bioinformatics applications using advanced single-nucleotide polymorphism (SNP) technologies, taking the field of forensic DNA analysis to the next level.

Dr. Sandra Close has greater than 20 years in the management of large cross functional teams integrating business and science with Eli Lilly and Company, Caremark Inc, and Baxter International. Prior to joining the Center for Advanced Forensic DNA Analysis, she was CEO of GenEngine, a consulting firm specializing in providing comprehensive scientific strategies to biotechnology and pharmaceutical companies. She brings deep expertise in the application of new technologies to biological problems including the validation of complex assays. Proficient in solving complex scientific problems through the integration of information, she has successfully shepherded both new drug applications and device approvals through the United States Food and Drug Administration and European Medicines Agency. In addition, Sandy has years of experience utilizing epidemiology and statistical principles to identify the appropriate treatment paradigms to affect health outcomes.

"Sandy brings remarkable strengths and experience to our scientific capabilities and fast paced organization. As a company with game changing bioscience applications, moving proven whole genome array solutions into the field of forensic science, we needed someone who had the breadth of experience to understand complex array technology, genomic applications, statistical analysis and bio informatics to augment our seasoned forensic scientific capabilities. Sandy certainly meets these requirements and brings a new dimension to our team, especially in developmental validation and rigorous scientific review of our superior applications," said Michael Heffernan, CEO Genome ID Group.

Genome ID Group, LLC

Genome ID Group, LLC, d/b/a, The Center for Advanced Forensic DNA Analysis™ (CAFDA) is an advanced forensic DNA analysis company, providing services to law enforcement, the legal system, federal and local government, and the intelligence community, supporting those in the fight against crime and terror. CAFDA is fueled by the need for next generation technology solutions in the expeditious resolution of criminal casework. We are focused on identifying and applying solutions to fit the scientific tasks and casework needs for DNA identification, offering a choice of technology and scientific solutions that best fit client needs.

Our solutions are developed, validated and prepared for immediate use in forensic human identification. Our highly trained, proficiency tested analysts with demonstrated experience in DNA forensic laboratory skills and data interpretation are a highly trained multidisciplinary scientific team, with experience in mass disaster recovery and DoD deployment. CAFDA offers a choice in technology applications, utilizing STR and SNP technologies and QuantumSNP, Forensic Analysis, under the technical and operational leadership of Dr. Close.

To learn more about CAFDA, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Heffernan
Genome ID Group, LLC
+1 (252) 565-1625 Ext: 100
Email >
Visit website